Lupus Erythematosus Flashcards

1
Q

What are the cutaneous variants of Lupus?

A

Acute cutaneous lupus
- Localised
- Generalised
- TENS like

Subacute cutaneous lupus Erythematosus

Chronic Cutaneous Lupus Erythematosus
- Discoid Lupus
- Lupus Profundus
- Chilblain Lupus

Lupus Tumidus

Lupus Panniculitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is Lupus?

A

A chronic autoimmune condition (body attacks its own cells)

  • can be limited to the skin (connective tissue disease)
  • can be systemic / multisystem
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Who does Lupus effect?

A

Female > Male
Adults > Children
African Americans > Caucasians

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What causes cutaneous lupus?

A

Multifactorial

Genetic susceptibility
- High incidence among family members

Hormones (women during childbearing years)

Environmental factors
- Cigarette smoking
- Sun exposure
- Medications
- Viral infections

Innate and adaptive immune responses
- autoantibodies.

Triggers an inflammatory cascade of cytokine, chemokine and inflammatory cell responses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

If a patient has SCLE, what is the risk of developing SLE?

A

10% will develop SLE - clinically significant

(50% meet criteria)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the genes involved in SLE?

A

Genes that affect overall immunoreactivity

  • B and T cell function
    –> HLA DR
    –> PTPN22
    –> STAT4
  • innate immunity
    –> IRF5
    –> TREX1
    –>STAT4
  • immune complex clearance,
    –> C1Q
  • apoptosis
    –> STAT4
  • Ubiquitination
  • DNA methylation
  • Cellular adhesion
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the cutaneous manifestations of acute cutaneous LE?

A

Malar erythema
- transient (few hours to several weeks)
- following sun exposure
- resolves without scarring

  • typically nasolabial sparing

Can have a widespread eruption

Sparing of the knuckles

Periungal erythema and ragged cuticles

Oral ulceration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Malar rash is associated with lupus nephritis and anti-dsDNA antibodies? (T/F).

A

True - however not always ass with this.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the clinical features of malar erythema?

A

Bilateral cheeks affects
Nasolabial sparing

Can have:
- telangiectasias
- erosions
- dyspigmentation and
- epidermal atrophy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the extra-cutaneous organ systems invovled in SLE?

A

Kidneys - Lupus Nephritis
Pulmonary -
Joints
CNS
Cardiovascular
Haematological

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the clinical manifestations of Discoid Lupus?

A

Well defined, red, scaly plaques
Heal with atrophy, scarring and pigmentary changes

Scaly is thick and adherent
- sometimes the tic-tack sign

Normally limited to the head and neck
Can be more widespread
Alopecia when it occurs on the scalp

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Who does discoid lupus affect?

A

Females: Males = 2:1
Peak decade = 30s
Asian, Afro-Caribeans, Hispanic Americans

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What dieseases are associated with Discoid Lupus?

A

Porphyria (PCT, varigate porphyria and acute and EPP)
Pemphigus
Myasthenia Gravis
Thymoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the histological features of cutaneous Lupus? (8)

A

Lymphocytic interface dermatitis
Basal Layer Degeneration
Basement membrane thickening
Peri-vascular and peri-adnexal lymphohistiocytic infiltrate
Follicular plugging
Dermal mucinosis
Epidermal atrophy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the dermoscopic features of DLE?

A

Follicular keratotic plugs
White perifollicular halo,
White scale,
Speckled brown pigmentation,
White structureless areas
Arborising vessels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the pathophysiology of DLE?

Is it TH1 or TH2 based?
What cells are invovled?
What is the result on t

A

Interferons (type 1 and 3) induce Th1 based inflammation

predominantly lymphocytic infiltration

causes epidermal damage, basement membrane thickening and a scarring tissue response associated with a loss of follicular stem cells

Cells involved
- CD4, CD8, T cells, natural IFN-producing plasmacytic dendritic cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Triggering factors to DLE (7)

A

Trauma (inc X-rays and thermal burns)
Stress
UV exposure
Infection -
Drug
Seasonal Exacerbation (winter and summer)
Cold Exposure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What are the Trichoscopic features of DLE?

A

follicular red dots
large yellow dots
absent follicular openings
thick arborising vessels
speckled brown or blue-grey dots
discoloration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What is chillblain lupus?

Describe the clinical features

A

Subtype of chronic CLE
Painful or pruritic
Red to violaceous papules and plaques
Involving the hands and feet, involvement of the nose and ears can occur too
Ulceration, fissuring and hyperkeratosis can occur

Occurs in ~6% of patients with lupus

20
Q

What are common triggers for chilblain lupus?

A

Cold exposure
Damp exposure
Pregnancy

21
Q

Antibodies ass with chillblain Lupus?

A

a positive ANA, anti-Ro/SSA or anti-La/SSB

Some patients may have cryo-fibrinogenaemia or cold agglutinins.

22
Q

What are the risk factors for chillblain lupus

A

Female
Smoking
Markedly abnormal peripheral circulation with low resting blood flow

23
Q

Management of chillblain Lupus?

A

General:
- maintaining a warm core and peripheral temperature
- avoiding damp conditions.

Topical treatments
- high-potency corticosteroids
- tacrolimus
- pimecrolimus

Systemics:
- oral nifedipine
- hydroxychloroquine
- quinacrine
- mycophenolate mofetil
- JAK inhibitors

24
Q

How does lupus panniculitis present and who does it affect?

A

Middle aged women

chronic and recurring tender, red, indurated subcutaneous nodules or plaques

located on fatty areas of the body.
- proximal extremities, face, back and scalp

Long-term sequalae include
- ulceration, atrophy, calcinosis and disfigurement.

25
Q

What is lupus profundus

A

Lupus paniculitis with overlying DLE (occurs in 1/3 of patients with Lupus Paniculitis)

26
Q

What is the histology findings of lupus profundus?

A

lymphoplasmacytic
lobular or mixed panniculitis
hyalinising fat necrosis and lymphoid follicles

In chronic lesions - dermal or subcutaneous calcium deposits

27
Q

What is the treatment for lupus Profundus?

A

First Line:
- antimalarials

Adjunct:
- systemic corticosteroids (short term)

Intralesional steroids, dapsone, mycophenolate mofetil, ciclosporin, rituximab and intravenous immunoglobulins

28
Q

What are the key antibodies you in CLE? And rates of positivity / Associations

A

ANA - Positive in 60-80% of CLE
- DLE 5 - 17%
- SCLE - ~60 - 80%
- ACLE - 94 - 100%

Anti - dsDNA
- positive in ACLE
- 56 - 70% sensitivity
- ass with renal disease and poor prognosis

Anti Ro/SSA
- Positive in 70 - 90 % of SCLE
- Ass. with Neonatal Lupus
- Ass with Sjogrens
- can also be seen in DLE

Anti La / SSB
- positive in 30 - 50% of SCLE
- Ass. with Sjogrens
- Can also be seen in DLE

Anti Sm
- Specific to LE
- present in 19 - 25%

Anti U1 RNP
- 23 - 49% of SLE
- 8 - 10% of ACLE
- rare in CLE

29
Q

How would you work up someone you suspect has lupus?

A

Ix to confirm diagnosis and exclude Ddx
- Histology –> interface dermatitis
- DIF –> DEJ staining for C3 / IgG (occ IgM)

  • ANA, ds-DNA, ENA
  • Complement (c3 / c4)(
  • CRP, ESR
  • RF
  • Antiphospholipid Abx (anti - cardiolipin, Beta 2 micro globulin and lupus anticoagulant)
  • CK
  • Myositis panel
  • serum IgE
  • FBC, UEC, LFTs

Ix for associations:
- Urine ACR
- Urine MCS for protein casts
- Consider joint imaging
- MRI brain
- Renal biopsy
- CTPA / PFTs
- TFTs, thyroid Abs

Pre-Rx
- vitamin D
- baseline eye assessment
- G6PD
- pre- immunosuppression screen

30
Q

What is the risk of progression to SLE for the different subtypes of CLE?

A
  1. ACLE: 90 - 100%
  2. SCLE: 50% meet criteria, only 10% will develop clinically significant systemic disease
  3. DLE: 5% in limited disease, 15% in generalised disease

Negligible risk fo lupus tumidus

31
Q

What percentage of SCLE cases are drug induced?

And what epidemiological factors would make you think of drug?

A

(33%) - 1/3 of cases

Older age
Widespread disease
Bullous or targeted lesions

32
Q

Common Drugs for Drug induced SCLE

A
  1. Anti-fungals
    - Terbinafine
  2. Anti-hypertensives
    - Thiazide diuretics
    - Calcium channel blocker
    - ACEi
  3. NSAIDs
  4. Anti-coagulants
    - Apixaban / rixaroxiban
  5. Chemotherapy
  6. Immunotherapy
    - ICIs
  7. PPIs
  8. Statins
33
Q

Drugs that can cause DLE?

A

Very rare

Pembrolizumab
TNF alpha
5 FU

34
Q

Approach to treatment for Cutaneous Lupus?

A

GENERAL MEASURES

Strict photo-protection (UVA and UVB)
- avoid peak UV times (11 - 3pm)
- Long sleeve pants and shirts with adequate clothing weave
- Broad brimmed hat
- Tint car windows (UVA)
- suncream: 50+, UVA, UVB protection - 2mg / cm2 applied 20 - 30 mins prior to sun exposure

Avoid photo-sensitising agents (tetracyclines, frusemide, NSAIDS, HCT)

Vit D and calcium supplements

Cosmetic camouflage with green tints

Stop smoking

TOPICALS
- steroids in an ointment base; twice daily for up to 4 weeks, then Rx break
- Intralesional steroids (2.5-5mg /ml on the face; 10mg/ml on the body)
- Topical calcinurin inhibitors

PHYSICAL Therapies
- C02 laser for DLE
- Pulse Dye Laser - DLE, SCLE - limited evidence

SYSTEMICS

HCQ response rates 50 - 95%
- <5mg / kg to reduce risk of ocular SEs
Other antimalarials Mepacrine quinacrine - lowest retinopathy risk
Chloroquine - can use as combination Rx

2nd line
- oral corticosteroids (up to 1mg/ day)
- MTx
- Acitretin and isotretinoin
- Dapsone
- MMF

3rd line
- thalidomide
- lenalidomide
- ivig
- clofazimine

35
Q

What is Rowell Syndrome?

A

Rare entity

Erythema multiforme-like lesions coexisting with lupus erythematosus (LE)

characteristic immunological findings
- Speckled ANA
- Postive RF
-Anti Sj - T

36
Q

Treatment of CLE in Pregnancy

A

HCQ - cat D, however first line

Dapsone + Folic acid second line

37
Q

What are the non-specific cutaneous features of lupus?

A

Raynaud’s

Livedo reticularis

Palmar erythema

Nail for telangiectasia’s, splinter haemorrhages

Vasculitis - pupura, urticarial papules or ulcers

Atrophie blanche
- livedo reticularis, thromboses, ulcerations, and lesions resembling Degos disease have each been associated with antiphospholipid antibodies

Alopecia

Sclerodactyl, calcinosis, rheumatoid nodules
Erythromelegia
Papulonodular mucinosis

Periorbital oedema

Sweet syndrome like presentation

38
Q

Ddx of SLE

A

Contact dermatitis,
Seborrhoeic dermatitis,
Dermatomyositis,
Erysipelas,
Rheumatoid arthritis,
Sjogren’s (almost all SLE cases have some features of Sjogren’s),
Sweet’s

39
Q

What are the nail changes that might be seen in SLE? (6)

What % of patients have nail changes?

A

Nail changes (25%):
- splinter haemorrhages,
- pitting,
- ridging,
- onycholysis,
- striate leukonychia
- red lunulae

40
Q

Associations with SLE?

A

Rheumatoid arthritis,
Systemic sclerosis,
Lichen sclerosus,
Morphoea,
Sjogren’s,

Primary biliary cirrhosis,
Myasthenia gravis/thymoma,

Angioedema from C1-esterase deficiency,

Hashimoto’s thyroiditis,
Pernicious anaemia,

Lymphoma, haemolytic anaemia, internal malignancy (debatable)

41
Q

Prognosis of DLE

A

Tends to be chronic, eventually remits in 50%

5% risk of developing SLE (20% in disseminated DLE)

risk factors: generalised DLE, lymphadenopathy, C1q on IF, HLA-B8

42
Q

Prognosis of SCLE

A

Mainly cutaneous disease
50% fulfil the criteria for SLE
Only 10% have clinically significant features

Risk factors for development of SLE: papulosquamous, leukopaenia, ANA >640, dsDNA positive

43
Q

What nail findings might you find in Lupus

A

Peri-ungal erythema
Splinter Haemmorrhage
Pitting
Ridges
Erythronychia
Onycholysis

44
Q

What types of Alopecia might you see in Lupus?

A

AA - AI association
Telogen Effluvium (stress)
Lupus Hairs (short, fragile hairs, frontal hairline)

45
Q

What are markers of disease activity is SLE?

A

CRP, ESR
dsDNA
C3 / C4

46
Q

What haematological findings might you see in SLE?

A

Anaemia
- due to haemolysis
- due to chronic disease

Thrombocytopaenia

Leukocytosis (or paenia)

Neuropaenia

47
Q

What antibodies may be positive on ENA?

A

Anti SSA / Ro
Anti SSB / La
Anti Smith
Anti U1RNP (MCTD)